Literature DB >> 8506620

Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma.

K Shimaya1, H Shiozaki, M Inoue, H Tahara, T Monden, T Shimano, T Mori.   

Abstract

The tumour suppressor gene product p53 is believed to play an important role in the progression of human malignant tumours through mutation and over-expression. Using a microwave oven heating method, we have detected over-expression of p53 in buffered-formalin fixed, paraffin-embedded sections of oesophageal carcinomas immunohistochemically and examined the relationship between the p53 over-expression and postoperative survival. Employing a monoclonal antibody (pAb1801), nuclear p53 was detected in 56 of 105 (53%) tumour specimens. Homogeneous, heterogeneous, and focal immunostaining patterns were noted. No immunostaining was found in adjacent benign tissues. The results in buffered-formalin fixed sections were similar to those in the frozen sections. The cumulative survival rate of patients with p53 expression was significantly lower than that of the patients without expression (P < 0.05), even though there were no significant differences between the clinicopathological features of the two groups. The results indicate that the nuclear accumulation of p53 might be an independent prognostic factor in patients with oesophageal squamous cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8506620     DOI: 10.1007/BF01608335

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  23 in total

1.  Localization of gene for human p53 tumour antigen to band 17p13.

Authors:  M Isobe; B S Emanuel; D Givol; M Oren; C M Croce
Journal:  Nature       Date:  1986 Mar 6-12       Impact factor: 49.962

2.  Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro.

Authors:  J Bártek; J Bártková; B Vojtĕsek; Z Stasková; A Rejthar; J Kovarík; D P Lane
Journal:  Int J Cancer       Date:  1990-11-15       Impact factor: 7.396

3.  p53 expression and prognosis in gastric carcinoma.

Authors:  H M Martin; M I Filipe; R W Morris; D P Lane; F Silvestre
Journal:  Int J Cancer       Date:  1992-04-01       Impact factor: 7.396

4.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

5.  Wild-type p53 can inhibit oncogene-mediated focus formation.

Authors:  D Eliyahu; D Michalovitz; S Eliyahu; O Pinhasi-Kimhi; M Oren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry.

Authors:  B J Kerns; P A Jordan; M B Moore; P A Humphrey; A Berchuck; M F Kohler; R C Bast; J D Iglehart; J R Marks
Journal:  J Histochem Cytochem       Date:  1992-07       Impact factor: 2.479

7.  Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer.

Authors:  W P Bennett; M C Hollstein; A He; S M Zhu; J H Resau; B F Trump; R A Metcalf; J A Welsh; C Midgley; D P Lane
Journal:  Oncogene       Date:  1991-10       Impact factor: 9.867

8.  p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters.

Authors:  A M Thompson; T J Anderson; A Condie; J Prosser; U Chetty; D C Carter; H J Evans; C M Steel
Journal:  Int J Cancer       Date:  1992-02-20       Impact factor: 7.396

9.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

10.  p53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis.

Authors:  G Tamura; C Maesawa; Y Suzuki; R Satodate; K Ishida; K Saito
Journal:  Jpn J Cancer Res       Date:  1992-06
View more
  16 in total

1.  Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy.

Authors:  Tedros Bezabeh; Olva Odlum; Richard Nason; Paul Kerr; Donna Sutherland; Rakesh Patel; Ian C P Smith
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

2.  p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma.

Authors:  Asuka Murata; Yoshifumi Baba; Masayuki Watanabe; Hironobu Shigaki; Keisuke Miyake; Ryuichi Karashima; Yu Imamura; Satoshi Ida; Takatsugu Ishimoto; Shiro Iwagami; Yasuo Sakamoto; Yuji Miyamoto; Naoya Yoshida; Hideo Baba
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

3.  p53 is an independent prognostic factor in operable esophageal squamous cell carcinoma: a large-scale study with a long follow-up.

Authors:  Xiao-Ling Xu; Wei-Hui Zheng; Kai-Yi Tao; Xian-Xing Li; Wei-Zhen Xu; Yin Wang; Shuang-Mei Zhu; Wei-Min Mao
Journal:  Med Oncol       Date:  2014-10-01       Impact factor: 3.064

4.  p53 and cyclin A protein expression in squamous carcinoma of the oesophagus.

Authors:  R Chetty; S Simelane
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

5.  Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor).

Authors:  S Inada; T Koto; K Futami; S Arima; A Iwashita
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

6.  p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival.

Authors:  A G Casson; M Tammemagi; S Eskandarian; M Redston; J McLaughlin; H Ozcelik
Journal:  Mol Pathol       Date:  1998-04

7.  Expression of the p53 protein in malignant melanomas as a prognostic indicator.

Authors:  M Yamamoto; H Takahashi; K Saitoh; T Horikoshi; M Takahashi
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

8.  Frequency and spectrum of p53 mutations in gastric cancer--a molecular genetic and immunohistochemical study.

Authors:  C Poremba; D W Yandell; Q Huang; J B Little; W Mellin; K W Schmid; W Böcker; B Dockhorn-Dworniczak
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 9.  The clinical significance of p53 aberrations in human tumours.

Authors:  S Bosari; G Viale
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma.

Authors:  T Ishikawa; M Furihata; Y Ohtsuki; H Murakami; A Inoue; S Ogoshi
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.